This site is intended for
Healthcare Providers Only

Video and Webcasts

Videos and Webcasts

EXPAREL® Video

Watch this short animation to see how EXPAREL works.

EXPAREL Video Modules

How EXPAREL Works
How EXPAREL Works
EXPAREL Pharmacokinetics
EXPAREL Pharmacokinetics
EXPAREL Dosing
EXPAREL Dosing
Administering EXPAREL
Administering EXPAREL
EXPAREL Infiltration Technique
EXPAREL Infiltration Technique
EXPAREL Storage & Handling
EXPAREL Storage & Handling
Administration Precautions With EXPAREL
Administration Precautions With EXPAREL
EXPAREL Infiltration Video for an Open Colectomy by Colorectal Surgeon Stephen Cohen MD, FACS, FASCRS.
EXPAREL Infiltration Technique for an Open Colectomy Procedure
EXPAREL Infiltration Video for an Abdominoplasty Procedure by Richard A. Baxter MD.
EXPAREL Infiltration Technique for an Abdominoplasty Procedure
EXPAREL Infiltration Video for an Abdominoplasty Procedure.
EXPAREL Infiltration Technique for an Abdominoplasty Procedure

On the Cutting Edge Simulcast Presentation

Postsurgical Pain Management
Postsurgical Pain Management
EXPAREL Data Presentation
EXPAREL Data Presentation
Dosing, Administration, and Storage
Dosing, Administration, and Storage
Benefits of EXPAREL

The EXPAREL Difference

Learn about the benefits of this innovative, non-opioid analgesic. > More

Is EXPAREL Right for My Patients

Is EXPAREL Right for My Patients

Find out if EXPAREL could meet a need in your practice. > More

These are not all of the potential important safety considerations for EXPAREL, please see the full Prescribing Information.

Important Safety Information

EXPAREL is contraindicated in obstetrical paracervical block anesthesia. EXPAREL has not been studied for use in patients younger than 18 years of age.


Non-bupivacaine-based local anesthetics, including lidocaine, may cause an immediate release of bupivacaine from EXPAREL if administered together locally. The administration of EXPAREL may follow the administration of lidocaine after a delay of 20 minutes or more. Other formulations of bupivacaine should not be administered within 96 hours following administration of EXPAREL.


Monitoring of cardiovascular and neurological status, as well as vital signs should be performed during and after injection of EXPAREL as with other local anesthetic products. Because amide-type local anesthetics, such as bupivacaine, are metabolized by the liver, EXPAREL should be used cautiously in patients with hepatic disease. Patients with severe hepatic disease, because of their inability to metabolize local anesthetics normally, are at a greater risk of developing toxic plasma concentrations.


In clinical trials, the most common adverse reactions (incidence ≥10%) following EXPAREL administration were nausea, constipation, and vomiting. Please see the full Prescribing Information for EXPAREL.

EXPAREL® Sign Up


Sign up to receive updates on EXPAREL.

Required*

First name*

Last name*

E-mail*

ZIP code*

Providing the optional information about you below enables us to provide information geared to your needs.

Specialty


Yes, I would like to receive periodic updates about EXPAREL via e-mail. I agree to the Privacy Policy.
Submit

Thank you! Your registration is complete.

Sorry. There was an error submitting your request. Please try again at another time.

Sorry. The connection to the server was lost. Please try again at another time.

EXPAREL® E-mail


Required*

Your name:*

Your colleague's name:*

Your colleague's e-mail address:*
To learn about our use of your information and your rights, please consult our Privacy Policy.
Submit
Reset

Your email has been sent.
Thank you!

The email address you entered was invalid.

Unfortunately, your email could not be sent at this time.